127 related articles for article (PubMed ID: 38242569)
1. Ecological study estimating melanoma overdiagnosis in the USA using the lifetime risk method.
Adamson AS; Naik G; Jones MA; Bell KJ
BMJ Evid Based Med; 2024 May; 29(3):156-161. PubMed ID: 38242569
[TBL] [Abstract][Full Text] [Related]
2. Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US.
Adamson AS; Suarez EA; Welch HG
JAMA Dermatol; 2022 Apr; 158(4):426-431. PubMed ID: 35293957
[TBL] [Abstract][Full Text] [Related]
3. Risk-adjusted melanoma skin cancer incidence rates in Whites (United States).
Merrill RM
Melanoma Res; 2011 Dec; 21(6):535-40. PubMed ID: 21730876
[TBL] [Abstract][Full Text] [Related]
4. Estimating the magnitude of cancer overdiagnosis in Australia.
Glasziou PP; Jones MA; Pathirana T; Barratt AL; Bell KJ
Med J Aust; 2020 Mar; 212(4):163-168. PubMed ID: 31858624
[TBL] [Abstract][Full Text] [Related]
5. The effect of screening on melanoma incidence and biopsy rates.
Whiteman DC; Olsen CM; MacGregor S; Law MH; Thompson B; Dusingize JC; Green AC; Neale RE; Pandeya N;
Br J Dermatol; 2022 Oct; 187(4):515-522. PubMed ID: 35531668
[TBL] [Abstract][Full Text] [Related]
6. An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975-2017.
Kurtansky NR; Dusza SW; Halpern AC; Hartman RI; Geller AC; Marghoob AA; Rotemberg VM; Marchetti MA
J Invest Dermatol; 2022 Jul; 142(7):1804-1811.e6. PubMed ID: 34902365
[TBL] [Abstract][Full Text] [Related]
7. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
[TBL] [Abstract][Full Text] [Related]
8. Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.
Wei EX; Qureshi AA; Han J; Li TY; Cho E; Lin JY; Li WQ
J Am Acad Dermatol; 2016 Oct; 75(4):698-705. PubMed ID: 27436155
[TBL] [Abstract][Full Text] [Related]
9. Evidence concerning the accusation that melanoma is overdiagnosed.
Muzumdar S; Lin G; Kerr P; Grant-Kels JM
J Am Acad Dermatol; 2021 Oct; 85(4):841-846. PubMed ID: 34116095
[TBL] [Abstract][Full Text] [Related]
10. Dermatopathologist Perceptions of Overdiagnosis of Melanocytic Skin Lesions and Association With Diagnostic Behaviors.
Kerr KF; Eguchi MM; Piepkorn MW; Radick AC; Reisch LM; Shucard HL; Knezevich SR; Barnhill RL; Elder DE; Elmore JG
JAMA Dermatol; 2022 Jun; 158(6):675-679. PubMed ID: 35442415
[TBL] [Abstract][Full Text] [Related]
11. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
[TBL] [Abstract][Full Text] [Related]
12. Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006.
Weir HK; Marrett LD; Cokkinides V; Barnholtz-Sloan J; Patel P; Tai E; Jemal A; Li J; Kim J; Ekwueme DU
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S38-49. PubMed ID: 22018066
[TBL] [Abstract][Full Text] [Related]
13. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
[TBL] [Abstract][Full Text] [Related]
14. Skin cancer. Melanoma and other specific nonmelanoma skin cancers.
Elder DE
Cancer; 1995 Jan; 75(1 Suppl):245-56. PubMed ID: 8000999
[TBL] [Abstract][Full Text] [Related]
15. Screening for reducing morbidity and mortality in malignant melanoma.
Johansson M; Brodersen J; Gøtzsche PC; Jørgensen KJ
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012352. PubMed ID: 31157404
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of second primary cancers after a diagnosis of melanoma.
Bradford PT; Freedman DM; Goldstein AM; Tucker MA
Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496
[TBL] [Abstract][Full Text] [Related]
17. Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach.
Pathirana T; Hayen A; Doust J; Glasziou P; Bell K
BMJ Open; 2019 Mar; 9(3):e022457. PubMed ID: 30858156
[TBL] [Abstract][Full Text] [Related]
18. The systematic relationship between melanomas diagnosed in situ and when invasive.
Lee JA
Melanoma Res; 2001 Oct; 11(5):523-9. PubMed ID: 11595891
[TBL] [Abstract][Full Text] [Related]
19. Age-Specific Incidence of Melanoma in the United States.
Paulson KG; Gupta D; Kim TS; Veatch JR; Byrd DR; Bhatia S; Wojcik K; Chapuis AG; Thompson JA; Madeleine MM; Gardner JM
JAMA Dermatol; 2020 Jan; 156(1):57-64. PubMed ID: 31721989
[TBL] [Abstract][Full Text] [Related]
20. Seasonal variation in frequency of diagnosis of cutaneous malignant melanoma.
Braun MM; Tucker MA; Devesa SS; Hoover RN
Melanoma Res; 1994 Aug; 4(4):235-41. PubMed ID: 7950359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
